Cytokinetics (NASDAQ:CYTK) Upgraded by Morgan Stanley to Overweight Rating
Morgan Stanley upgraded shares of Cytokinetics (NASDAQ:CYTK – Free Report) from an equal weight rating to an overweight rating in a research note issued to...
JMP Securities Issues Positive Forecast for CyberArk Software (NASDAQ:CYBR) Stock Price
CyberArk Software (NASDAQ:CYBR – Get Free Report) had its price target increased by equities research analysts at JMP Securities from $390.00 to $480.00 in a...
Charles & Colvard, Ltd. (NASDAQ:CTHR) Coverage Initiated at StockNews.com
Stock analysts at StockNews.com started coverage on shares of Charles & Colvard, Ltd. (NASDAQ:CTHR – Get Free Report) in a note issued to investors on...
CureVac (NASDAQ:CVAC) Earns “Market Outperform” Rating from JMP Securities
CureVac (NASDAQ:CVAC – Get Free Report)‘s stock had its “market outperform” rating restated by investment analysts at JMP Securities in a research report issued to...
Barclays PLC (LON:BARC) Receives GBX 294 Average PT from Analysts
Shares of Barclays PLC (LON:BARC – Get Free Report) have been assigned an average recommendation of “Buy” from the seven research firms that are presently...
Truist Financial Forecasts Strong Price Appreciation for CyberArk Software (NASDAQ:CYBR) Stock
CyberArk Software (NASDAQ:CYBR – Get Free Report) had its price objective upped by equities researchers at Truist Financial from $385.00 to $450.00 in a research...